These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1550241)

  • 21. Vascular effects of platelet-activating factor in lambs: role of cyclo- and lipoxygenase.
    Toga H; Hibler S; Ibe BO; Raj JU
    J Appl Physiol (1985); 1992 Dec; 73(6):2559-66. PubMed ID: 1490969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet-activating factor and the kidney.
    Schlondorff D; Neuwirth R
    Am J Physiol; 1986 Jul; 251(1 Pt 2):F1-11. PubMed ID: 3089026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of inhaled lyso-platelet-activating factor on airway microvascular leakage in the guinea pig.
    Sakamoto T; Elwood W; Barnes PJ; Chung KF
    J Appl Physiol (1985); 1993 Mar; 74(3):1117-22. PubMed ID: 8482649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the contractile and calcium-increasing properties of platelet-activating factor and endothelin-1 in the rat mesenteric artery and vein.
    Claing A; Shbaklo H; Plante M; Bkaily G; D'Orléans-Juste P
    Br J Pharmacol; 2002 Jan; 135(2):433-43. PubMed ID: 11815379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence that platelet activating factor may mediate some acute inflammatory responses. Studies with the platelet-activating factor antagonist, CV3988.
    Issekutz AC; Szpejda M
    Lab Invest; 1986 Mar; 54(3):275-81. PubMed ID: 3951199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet-activating factor and bacteremia-induced pulmonary hypertension.
    Clavijo LC; Carter MB; Matheson PJ; Wills-Frank LA; Wilson MA; Wead WB; Garrison RN
    J Surg Res; 2000 Feb; 88(2):173-80. PubMed ID: 10644485
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of prostaglandins in angiotensin II-induced gastric vasoconstriction.
    Wood JG; Yan ZY; Cheung LY
    Am J Physiol; 1994 Aug; 267(2 Pt 1):G173-9. PubMed ID: 8074217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of pulmonary and systemic vascular responses to platelet-activating factor in the cat.
    Bellan JA; Minkes RK; Hood JS; McMahon TJ; Higuera TR; Nossaman BD; McNamara DB; Kadowitz PJ
    Am J Physiol; 1992 Jul; 263(1 Pt 2):H234-43. PubMed ID: 1379004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aging and vasoreactivity: in vivo responses in the beagle hindlimb.
    Haidet GC; Wennberg PW; Rector TS
    Am J Physiol; 1995 Jan; 268(1 Pt 2):H92-9. PubMed ID: 7840307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resistance and exchange microvessels are modulated by different PAF receptors.
    Tomeo AC; Durán WN
    Am J Physiol; 1991 Nov; 261(5 Pt 2):H1648-52. PubMed ID: 1659229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The responses of pulmonary and systemic circulation and airway to anaphylactic mediators in anesthetized BALB/c mice.
    Wang M; Shibamoto T; Kuda Y; Tanida M; Zhang T; Song J; Kurata Y
    Life Sci; 2016 Feb; 147():77-84. PubMed ID: 26808090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of platelet-activating factor in conscious, normotensive endotoxemia.
    Ephgrave K; Kremer T; Broadhurst K; Cullen J
    J Surg Res; 1997 Mar; 68(2):170-4. PubMed ID: 9184676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of neutrophil depletion and repletion on PAF-induced hyperresponsiveness of canine trachea.
    Bethel RA; Worthen GS; Henson PM; Lien DC
    J Appl Physiol (1985); 1992 Dec; 73(6):2413-9. PubMed ID: 1490952
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of platelet activating factor (PAF) on blood flow distribution in the spontaneously hypertensive rat.
    Goldstein BM; Gabel RA; Huggins FJ; Cervoni P; Crandall DL
    Life Sci; 1984 Sep; 35(13):1373-8. PubMed ID: 6482659
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PAF increases capillary pressure but not vascular permeability in isolated blood-perfused canine lungs.
    Shibamoto T; Yamaguchi Y; Hayashi T; Saeki Y; Kawamoto M; Koyama S
    Am J Physiol; 1993 May; 264(5 Pt 2):H1454-9. PubMed ID: 8498559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gastric mucosal damage induced by local intra-arterial administration of Paf in the rat.
    Esplugues JV; Whittle BJ
    Br J Pharmacol; 1988 Jan; 93(1):222-8. PubMed ID: 3349230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet activating factor-induced microvascular permeability increases in the cat hindlimb.
    Lu Z; Wolf MB
    Circ Shock; 1993 Sep; 41(1):8-18. PubMed ID: 8403248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelet-activating factor potentiates protamine-induced lung edema. Role of eicosanoids.
    Chen CR; Voelkel NF; Chang SW
    Am J Respir Crit Care Med; 1994 Jan; 149(1):34-40. PubMed ID: 8111595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fetal pulmonary vasodilation after exogenous platelet-activating factor.
    Accurso FJ; Abman SH; Wilkening RB; Worthen GS; Henson P
    J Appl Physiol (1985); 1991 Feb; 70(2):778-87. PubMed ID: 2022570
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of Nitric oxide in the renal and systemic vasodilatory responses to platelet-activating factor in the rat, in vivo.
    Handa RK; Strandhoy JW; Handa SE
    Kidney Blood Press Res; 2003; 26(3):165-75. PubMed ID: 12886044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.